- Research works
- 22 ▼ 50% vs 2013–17
- Citations
- 1k 46.6 per fractional work
- Top-10% rate
- 19.8% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Senex Biotechnology (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 6.8×. Every wedge is a field page.
Which keywords describe research at Senex Biotechnology (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Breast Cancer, Cancer Therapy, Immune Response, CDK4/6 Inhibitors, Palbociclib, Glycosylation and Antiviral Therapy.
- p53
- Monoclonal Antibodies
- Regulation
- Drug Resistance
- Healthcare-Associated Infections
- Treatment
- Antiviral Therapy
- CDK4/6 Inhibitors
- Cancer Therapy
- Cancer
- Epidemiology
- Breast Cancer
- Immune Response
- Palbociclib
- Glycosylation
- Liver Disease
- Antiretroviral Therapy
- HIV Infection
- Cell Cycle
- Therapeutic Antibodies
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Epidemiology2▲ 2.6×7 topics
- Cancer2▲ 6.8×12 topics
- Breast Cancer2▲ 31×3 topics
- Cancer Therapy2▲ 13×6 topics
- Immune Response2▲ 13×6 topics
- CDK4/6 Inhibitors2▲ 466×1 topic
- Palbociclib2▲ 466×1 topic
- Antiviral Therapy2▲ 45×3 topics
- Glycosylation2▲ 32×3 topics
- Treatment2▲ 5.5×3 topics
- Liver Disease1▲ 46×2 topics
- Healthcare-Associated Infections1▲ 51×4 topics
- Antiretroviral Therapy1▲ 24×2 topics
- Drug Resistance1▲ 16×1 topic
- HIV Infection1▲ 40×1 topic
- Regulation1▲ 8.7×2 topics
- Cell Cycle1▲ 84×1 topic
- Monoclonal Antibodies1▲ 33×2 topics
- Therapeutic Antibodies1▲ 37×2 topics
- p531▲ 111×1 topic
Which research topics does Senex Biotechnology (United States) publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, Ovarian cancer diagnosis and treatment, Protein Degradation and Inhibitors and Global Energy Security and Policy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
- 3 Protein Degradation and Inhibitors Molecular Biology 0 works
- 4 Global Energy Security and Policy General Energy 0 works
- 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
- 6 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 7 Mass Spectrometry Techniques and Applications Spectroscopy 0 works
- 8 Ubiquitin and proteasome pathways Molecular Biology 0 works
- 9 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
- 10 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Senex Biotechnology (United States)'s research output changed?
Output in 2018–2022 was 50% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Columbia
- University of South Carolina
- Columbia College - South Carolina
- Palmetto Health Richland
- South Carolina Department of Natural Resources
- SleepMed
- South Carolina Department of Education
- Benedict College
- Wm. Jennings Bryan Dorn VA Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.